Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity

AIMS: Myocarditis is often associated with parvovirus B19 (B19V) persistence, which can induce vascular damage. Based on the antiviral and anti‐inflammatory properties of telbivudine, we aimed to evaluate its efficacy to protect B19V‐infected endothelial cells in vitro and to treat chronic lymphocyt...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Van Linthout, Sophie, Elsanhoury, Ahmed, Klein, Oliver, Sosnowski, Marzena, Miteva, Kapka, Lassner, Dirk, Abou‐El‐Enein, Mohamed, Pieske, Burkert, Kühl, Uwe, Tschöpe, Carsten
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6165949/
https://ncbi.nlm.nih.gov/pubmed/30099854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12341
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars